Cholesterol

Advertisement

cGxPJobs Banner

Amgen Shows Repatha Reduces Death Risk in High-Risk Patients

Thousand Oaks, Calif. – August 31, 2026 Amgen announced new Phase 3 findings showing that Repatha® (evolocumab) reduced the...

By cGxPwire Editor
September 1, 2026

Read More

Advertisement

cGxPJobs

Directory